skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

99+ Total results for product and free and sample content found

Medtech Insight

Medtech Insight Awards Return to Medtech Conference for Second Year

17 Apr 2019

Informa Pharma Intelligence is pleased to announce that The Medtech Insight Awards is returning for their second year.  The awards will be held during The MedTech Conference, on September 23, 2019 in Boston, Massachusetts.

Topic Medtech

Datamonitor Healthcare

Market Access Data that makes sense

17 Apr 2019

How can you find current quantitative and qualitative evidence that informs your market access strategy?

Topic Reimbursement

Citeline, Pharmaprojects

Pharma RD Annual Review 2019 Supplement New Active Substances Launched During 2018

17 Apr 2019

Take the analysis from the Informa Pharma Intelligence R&D Annual Review 2019 further with the Pharma R&D Annual Review 2019 Supplement: New Active Substances Launched During 2018. This essential whitepaper uses critical data from Pharmaprojects to examine the new entities that were successfully launched to market last year.

Topic Drug approval Drug development landscape Drug review

Citeline, Pharmaprojects

New Active Substances (NAS) LAUNCHED DURING 2018

17 Apr 2019

For a snapshot of the new active substances (NAS) successfully launched last year, download the data-packed New Active Substances (NAS) Launched During 2018 infographic from Citeline.

Topic Drug approval Drug development landscape Drug review

Datamonitor Healthcare

HIV Market Growth webinar

By Michael ​ Haydock 15 Apr 2019

Mr. Haydock & Mr. Haas used the exclusive information within Datamonitor Healthcare and Biomedtracker to present a view of the market for HIV drugs. Informa Pharma Intelligence forecasts HIV sales revenues to increase in the US and five major EU markets to a peak of $22.7bn in 2024 before generic erosion triggers a market decline.

Datamonitor Healthcare

Lysosomal Storage Disorders (LSDs): Epidemiology & Treatment Overview

By Niharika Dandamudi 15 Apr 2019

Lysosomal storage diseases (LSDs) are a rare distinct group of disorders with complex diagnosis and limited epidemiology data, such as Pompe disease. In recognition of International Pompe Day, marked on April 15, we created the below infographic to provide some insight into epidemiology and present an overview of current treatment options.

Topic Diseases

Scrip

A timeline of the Takeda/Shire merger

By Mike Ward 15 Apr 2019

A staple of consumer magazines and tabloid newspapers involves coverage of celebrity relationships – who has been seen together? Who is dating? Will they become a permanent item? And are they going to live happily ever after? Readers can’t seem to get enough of it. Interestingly, while maybe not so racy as the celebrity goings-on, pharma industry watchers are keen to follow company couplings. Talk of mergers and acquisitions, one of the ways that companies can build scale, always attracts attention.

Topic Business strategies Company analysis

Scrip

PBMs Were On Capitol Hill, But Pharma Still Took Some Heat

By Jessica Merrill 11 Apr 2019

Drug makers remained front and center during the Senate Finance Committee's third hearing on drug pricing, even though leaders from five pharmacy benefit managers were testifying.

Topic Drug approval Drug development landscape Drug review

Scrip

Finance Watch: Q1 Biopharma Venture Capital Dips From All-Time High, But Numbers Still Impress

By Mandy Jackson 11 Apr 2019

Private Company Edition: Biotech companies raised $3.9bn, down from $4.6bn in the first quarter of 2019 – a record-breaking year in the US – but dollars per deal stayed above $20m for a second year. Also, Fusion has April's second $100m-plus VC financing with a $105m Series B.

Topic BioPharmaceutical

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: